Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 3,985.00
+5.00 (0.13%)
Aug 25, 2026, 3:24 PM JST
Kaken Pharmaceutical Market Cap
Kaken Pharmaceutical has a market cap or net worth of 150.72 billion as of August 24, 2026. Its market cap has increased by 2.53% in one year.
Market Cap
150.72B
Enterprise Value
96.42B
Revenue
88.16B
Ranking
n/a
PE Ratio
14.62
Stock Price
3,985.00
ChartMarket Cap Chart
Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 150.72B, an increase of 27.32%. That is a compound annual growth rate of 0.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 150.72B | -0.87% |
| Dec 30, 2025 | 152.04B | -11.05% |
| Dec 30, 2024 | 170.93B | 34.53% |
| Dec 29, 2023 | 127.05B | -12.84% |
| Dec 30, 2022 | 145.77B | -8.45% |
| Dec 30, 2021 | 159.22B | 3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tsumura & Co. | 280.82B |
| Nippon Shinyaku | 247.16B |
| Towa Pharmaceutical | 191.74B |
| Sawai Group Holdings | 188.47B |
| Kissei Pharmaceutical | 169.75B |
| Mochida Pharmaceutical | 115.25B |
| Zeria Pharmaceutical | 94.90B |
| KYORIN Pharmaceutical | 66.52B |